Tempest Therapeutics, Inc. Operating Lease Right-of-Use Assets
Tempest Therapeutics, Inc. (TPST) had Operating Lease Right-of-Use Assets of $6.95 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-13
- 2026-06-30: Operating Lease, Right-of-Use Asset $6.95M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $7.25M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $7.54M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $7.83M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $6.95M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $7.25M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $7.54M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $7.83M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $8.10M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $8.38M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $8.64M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $8.90M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $9.16M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $9.51M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $9.95M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $10.38M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $10.80M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $11.22M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $11.65M 10-K · filed 2024-03-19 | |
| 2022-09-30 | $1.31M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $1.55M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.74M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.05M 10-K · filed 2023-03-22 | |
| 2021-09-30 | $3.36M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $3.67M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $3.05M 10-Q · filed 2022-05-13 | $2.01M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $1.88M 10-K · filed 2022-03-29 | $2.16M 10-K · filed 2021-03-29 |
| 2020-09-30 | $1.88M 10-Q · filed 2021-11-10 | $2.36M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $2.62M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $2.87M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $3.33M 10-K · filed 2021-03-29 | |
| 2019-09-30 | $3.57M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $2.35M 10-Q · filed 2019-08-12 | |
| 2019-03-31 | $797.00K 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |